Applied Therapeutics, Inc. — Form D
Applied Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-13. The offering totals $100.0M, of which $100.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-03-13
- Form: D
- Accession: 0000950172-24-000045
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $100.0M
- Amount sold: $100.0M
- Investors: 31
- Date of first sale: 2024-02-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-507505
Issuer
- Name: Applied Therapeutics, Inc.
- CIK: 0001697532
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY, 10017
- Phone: 212-220-9226
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Les Funtleyder | Director | New York, NY |
| Stacy J Kanter | Director | New York, NY |
| Teena J Lerner | Director | New York, NY |
| Joel S Marcus | Director | Pasadena, CA |
| Shoshana Shendelman | Director | New York, NY |
| Jay S Skyler | Director | New York, NY |
| Les Funtleyder | Executive Officer | New York, NY |
| Adam Hansard | Executive Officer | New York, NY |
| Riccardo Perfetti | Executive Officer | New York, NY |
| Shoshana Shendelman | Executive Officer | New York, NY |
| Catherine Thorpe | Executive Officer | New York, NY |
| Joel Marcus | Director | South San Francisco, CA |
| Franklin Berger | Director | Newark, CA |
| Mark Vignola | Executive Officer | New York, NY |
| Teena Lerner | Director | New York, NY |
Other filings by this issuer (5)
More